EXOSC9 Protein, Human (sf9, His)
EXOSC9 is a noncatalytic RNA exosome complex component that critically drives 3'->5' exoribonuclease activity and contributes to a variety of cellular RNA processing and degradation events. In the nucleus, it helps stabilize the maturation of RNA species and eliminates processing by-products, non-coding transcripts and defective mRNAs, thereby inhibiting their cytoplasmic export. EXOSC9 Protein, Human (sf9, His) is the recombinant human-derived EXOSC9 protein, expressed by Sf9 insect cells , with N-His labeled tag.
- Species: Human
- Source: Sf9 insect cells
-
Storage:Stored at -80°C for 1 year from date of receipt. It is stable at -20°C for 3 months after opening. It is recommended to freeze aliquots at -80°C for extended storage. Avoid repeated freeze-thaw cycles.
Biological Activity
Description
EXOSC9 is a noncatalytic RNA exosome complex component that critically drives 3'->5' exoribonuclease activity and contributes to a variety of cellular RNA processing and degradation events. In the nucleus, it helps stabilize the maturation of RNA species and eliminates processing by-products, non-coding transcripts and defective mRNAs, thereby inhibiting their cytoplasmic export. EXOSC9 Protein, Human (sf9, His) is the recombinant human-derived EXOSC9 protein, expressed by Sf9 insect cells , with N-His labeled tag.
Background
EXOSC9, a non-catalytic component of the RNA exosome complex, plays a crucial role in 3'->5' exoribonuclease activity and is actively involved in numerous cellular RNA processing and degradation events. Operating within the nucleus, the RNA exosome complex contributes to the proper maturation of stable RNA species, such as rRNA, snRNA, and snoRNA. Simultaneously, it facilitates the elimination of RNA processing by-products, non-coding 'pervasive' transcripts like antisense RNA species and promoter-upstream transcripts (PROMPTs), as well as mRNAs with processing defects, thereby restricting their export to the cytoplasm. The RNA exosome's potential involvement in Ig class switch recombination (CSR) and/or Ig variable region somatic hypermutation (SHM) is suggested, as it directs AICDA deamination activity to transcribed dsDNA substrates. In the cytoplasm, EXOSC9, as part of the RNA exosome complex, contributes to general mRNA turnover and specifically degrades inherently unstable mRNAs containing AU-rich elements (AREs) within their 3' untranslated regions. It also participates in RNA surveillance pathways, preventing the translation of aberrant mRNAs, and appears to be implicated in the degradation of histone mRNA. The catalytically inactive RNA exosome core complex of 9 subunits (Exo-9) is proposed to play a pivotal role in binding and presenting RNA for ribonucleolysis, functioning as a scaffold for the association with catalytic subunits and accessory proteins or complexes. Notably, EXOSC9 exhibits binding affinity for ARE-containing RNAs. As a component of the RNA exosome complex, it specifically participates in the Exo-9 complex, associating with catalytic subunits EXOSC10 and DIS3 or DIS3L in cytoplasmic- and nuclear-specific RNA exosome complex forms. Interactions with SETX, particularly via its C-terminus region, have been identified, and this interaction enhances SETX sumoylation.
Technical Parameters
-
Species Human
-
Source Sf9 insect cells
-
Tag N-His
-
Accession
Q06265-1/NP_005024.2 (M1-N439)
-
Molecular Construction
-
N-term
-
His
-
EXOSC9 (M1-N439)
Accession # Q06265-1/NP_005024.2 -
C-term
-
-
Protein Length
Full Length of Isoform-1
-
Synonyms
EXOSC9; Autoantigen PM/Scl 1; Prev. PMSCL1; P75 Polymyositis-Scleroderma Overlap Syndrome-Associated Autoantigen; PM/Scl-75; Polymyositis/Scleroderma Autoantigen 1 (75kD); Exosome Complex Component RRP45; Polymyositis/Scleroderma Autoantigen 75 KDa; Rrp45
-
AA Sequence
MKETPLSNCERRFLLRAIEEKKRLDGRQTYDYRNIRISFGTDYGCCIVELGKTRVLGQVSCELVSPKLNRATEGILFFNLELSQMAAPAFEPGRQSDLLVKLNRLMERCLRNSKCIDTESLCVVAGEKVWQIRVDLHLLNHDGNIIDAASIAAIVALCHFRRPDVSVQGDEVTLYTPEERDPVPLSIHHMPICVSFAFFQQGTYLLVDPNEREERVMDGLLVIAMNKHREICTIQSSGGIMLLKDQVLRCSKIAGVKVAEITELILKALENDQKVRKEGGKFGFAESIANQRITAFKMEKAPIDTSDVEEKAEEIIAEAEPPSEVVSTPVLWTPGTAQIGEGVENSWGDLEDSEKEDDEGGGDQAIILDGIKMDTGVEVSDIGSQDAPIILSDSEEEEMIILEPDKNPKKIRTQTTSAKQEKAPSKKPVKRRKKKRAAN
-
Predicted Molecular Mass
51.3 kDa
-
Purity
≥ 85%, as determined by reducing SDS-PAGE.
Product Properties
Solution
<1 EU/μg, determined by LAL method.
Stored at -80°C for 1 year from date of receipt. It is stable at -20°C for 3 months after opening. It is recommended to freeze aliquots at -80°C for extended storage. Avoid repeated freeze-thaw cycles.
Shipping with dry ice.
Documentation
-
Data Sheet (238 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
Handling Instructions (2659 KB)
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)